AAAAAA
Results:
1-10
|
Results: 10
Authors:
Salle, L
Eftekhari, P
Aupart, M
Cosnay, P
Hoebeke, J
Argibay, JA
Citation: L. Salle et al., Inhibitory activity of antibodies against the human atrial 5-HT4 receptor, J MOL CEL C, 33(3), 2001, pp. 405-417
Authors:
Mahler, E
Sepulveda, P
Jeannequin, O
Liegeard, P
Gounon, P
Wallukat, G
Eftekhari, P
Levin, MJ
Hoebeke, J
Hontebeyrie, M
Citation: E. Mahler et al., A monoclonal antibody against the immunodominant epitope of the ribosomal P2 beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor, EUR J IMMUN, 31(7), 2001, pp. 2210-2216
Authors:
Eftekhari, P
Roegel, JC
Lezoualc'h, F
Fischmeister, R
Imbs, JL
Hoebeke, J
Citation: P. Eftekhari et al., Induction of neonatal lupus in pups of mice immunized with synthetic peptides derived from amino acid sequences of the serotoninergic 5-HT4 receptor, EUR J IMMUN, 31(2), 2001, pp. 573-579
Authors:
Colombat, P
Salles, G
Brousse, N
Eftekhari, P
Soubeyran, P
Delwail, V
Deconinck, E
Haioun, C
Foussard, C
Sebban, C
Stamatoullas, A
Milpied, N
Boue, F
Taillan, B
Lederlin, P
Najman, A
Thieblemont, C
Montestruc, F
Mathieu-Boue, A
Benzohra, A
Solal-Celigny, P
Citation: P. Colombat et al., Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy forpatients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation, BLOOD, 97(1), 2001, pp. 101-106
Authors:
Fu, MLX
Herlitz, H
Schulze, W
Wallukat, G
Micke, P
Eftekhari, P
Sjogren, KG
Hjalmarson, A
Muller-Esterl, W
Hoebeke, J
Citation: Mlx. Fu et al., Autoantibodies against the angiotensin receptor (AT(1)) in patients with hypertension, J HYPERTENS, 18(7), 2000, pp. 945-953
Authors:
Eftekhari, P
Salle, L
Lezoualc'h, F
Mialet, J
Gastineau, M
Briand, JP
Isenberg, DA
Fournie, GJ
Argibay, J
Fischmeister, R
Muller, S
Hoebeke, J
Citation: P. Eftekhari et al., Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block, EUR J IMMUN, 30(10), 2000, pp. 2782-2790
Authors:
Mialet, J
Dahmoune, Y
Lezoualc'h, F
Berque-Bestel, I
Eftekhari, P
Hoebeke, J
Sicsic, S
Langlois, M
Fischmeister, R
Citation: J. Mialet et al., Exploration of the ligand binding site of the human 5-HT4 receptor by site-directed mutagenesis and molecular modeling, BR J PHARM, 130(3), 2000, pp. 527-538
Authors:
Mialet, J
Berque-Bestel, I
Eftekhari, P
Gastineau, M
Giner, M
Dahmoune, Y
Donzeau-Gouge, P
Hoebeke, J
Langlois, M
Sicsic, S
Fischmeister, R
Lezoualc'h, F
Citation: J. Mialet et al., Isolation of the serotoninergic 5-HT4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6-glial and CHO cell lines, BR J PHARM, 129(4), 2000, pp. 771-781
Authors:
Peukert, S
Fu, MLX
Eftekhari, P
Poepping, I
Voss, A
Thalhammer, C
Hempel, A
Menz, M
Dietz, R
Osterziel, KJ
Citation: S. Peukert et al., The frequency of occurrence of anti-cardiac receptor autoantibodies and their correlation with clinical manifestation in patients with hypertrophic cardiomyopathy, AUTOIMMUN, 29(4), 1999, pp. 291-297
Authors:
Fu, ML
Schulze, W
Wallukat, G
Elies, R
Eftekhari, P
Hjalmarson, K
Hoebeke, J
Citation: Ml. Fu et al., Immunohistochemical localization of angiotensin II receptors (AT1) in the heart with anti-peptide antibodies showing a positive chronotropic effect, RECEPT CHAN, 6(2), 1998, pp. 99
Risultati:
1-10
|